Search Results (93)

Background: Airborne transmission of bacteria, viruses, and fungal spores poses a major threat in enclosed settings, particularly nursing homes where residents are highly vulnerable. Compressive Heating Air Sterilization Technology (CHAST) applies compressive heating to inactivate microorganisms without reliance on filtration or chemicals. Methods: CHAST efficacy was evaluated in laboratory and deployed for a feasibility and performance validation study of air sterilization in a nursing home environment. Laboratory studies tested prototypes (300–5000 CFM; 220–247 °C) against aerosolized surrogates including Bacillus globigii (Bg), B. stearothermophilus (Bst), B. thuringiensis (Bt), Escherichia coli, and MS2 bacteriophage. Viral inactivation thresholds were further assessed by exposing MS2 to progressively lower treatment temperatures (64.5–143 °C). Feasibility and performance validation evaluation involved continuous operation of two CHAST units in a nursing home, with pre- and post-treatment air samples analyzed for bacterial and fungal burden. Results: Laboratory testing demonstrated consistent microbial inactivation, with most prototypes achieving > 6-log (99.9999%) reductions across bacterial spores, vegetative bacteria, and viruses. A 5000 CFM prototype achieved > 7-log (99.99999%) elimination of B. globigii. MS2 was completely inactivated at 240 °C, with modeling suggesting a threshold for total viral elimination near 170 °C. In the feasibility study, baseline sampling revealed bacterial (35 CFU/m³) and fungal (17 CFU/m³) contamination, dominated by Bacillus, Staphylococcus, Cladosporium, and Penicillium. After 72 h of CHAST operation, discharge air contained no detectable viable organisms, and fungal spore counts showed a 93% reduction relative to baseline return air. Units maintained stable operation (464 °F ± 2 °F; 329–335 CFM) throughout deployment. Conclusion: CHAST reproducibly and scalably inactivated airborne bacteria, viruses, and fungi under laboratory and feasibility field studies, supporting its potential as a chemical-free strategy to improve infection control and indoor air quality in healthcare facilities. Full article

Background/Objectives: Fibroblast activation protein (FAP) is highly expressed in tumor stroma and selected inflammatory conditions, offering a promising target for molecular imaging. [⁶⁸Ga]Ga-FAPI-46 is a DOTA-based FAP inhibitor with excellent tumor-to-background ratio and potential advantages over [¹⁸F]FDG in low-glycolytic tumors. This article aims to highlight the quality elements that are relevant to clinical practice and to describe the development of an investigational medicinal product dossier for a bicentric clinical trial involving [⁶⁸Ga]Ga-FAPI-46. Methods: The radiolabeling was performed by the two facilities using different automated synthesizers, but with the same specifications and acceptance criteria Results: Three validation batches per site were analyzed for radiochemical/radionuclidic purity, pH, endotoxin, sterility, and bioburden according to European Pharmacopoeia standards. Stability was as sessed up to 2 h post-synthesis. All batches met predefined acceptance criteria. Conclusions: Despite differences in radiosynthesizer modules, product quality and process reproducibility were maintained across both centers. [⁶⁸Ga]Ga-FAPI-46 can be reliably produced in academic settings under GMP-like conditions, enabling multicenter clinical research and facilitating IMPD submissions for broader adoption of FAP-targeted PET imaging. Full article

Background: Wide-awake local anesthesia with no tourniquet (WALANT) carpal tunnel release (CTR), performed in the clinic setting, has emerged as a safe, efficient, and cost-effective alternative to traditional operating room (OR)-based decompression. With increasing adoption in clinic settings, WALANT CTR offers the potential to improve access, reduce costs, and maintain excellent patient outcomes. Purpose: This clinical practice update provides an evidence-based summary of clinic-based WALANT CTR, including patient selection, procedural setup, safety profile, cost implications, and system-level considerations for implementation. Recent Findings: Multiple prospective and retrospective studies confirm the safety of WALANT CTR in the clinic setting, with complication rates comparable to OR-based procedures and no increase in surgical-site infections when field sterility is used. Cost analyses report a 70–85% reduction in facility costs per operative case, and patient satisfaction remains consistently high, even among those with anxiety disorders or psychiatric conditions. Adjunctive interventions such as virtual reality technology devices and noise-canceling headphones further enhance the awake surgical experience. Institutional adoption remains variable, with barriers including sterility concerns, billing uncertainty, and credentialing logistics. This clinical update offers detailed, practical guidance on implementing WALANT CTR for surgeons and staff, covering scheduling, staff training, clinical integration, billing, and compliance considerations. Summary: Clinic-based WALANT CTR is a high-value, patient-centered approach supported by a growing body of literature. With appropriate patient selection, streamlined workflows, and institutional support, this model can optimize surgical care delivery in both resource-rich and limited environments. Full article

This research presents the design and implementation of a cascade Proportional–Integral (PI) controller tailored for a Variable Air Volume (VAV) system that was specially created and executed particularly for hospital operating rooms. The main goal of this work is to make sure that the temperature and positive pressure stay within the limits set by ASHRAE Standard 170-2017. This is necessary for patient safety, surgical accuracy, and system reliability. The proposed cascade design uses dual-loop PI controllers: one loop controls the temperature based on user-defined setpoints by local control touch screen, and the other loop accurately modulates the differential pressure to keep the pressure of the environment sterile (positive pressure). The system works perfectly with Building Automation System (BAS) parts from Automated Logic Corporation (ALC) brand, like Direct Digital Controllers (DDC) and Web-CTRL software with Variable Frequency Drives (VFDs), advanced sensors, and actuators that give real-time feedback, precise control, and energy efficiency. The system’s exceptional responsiveness, extraordinary stability, and resilient flexibility were proven through empirical validation at the Korean Iraqi Critical Care Hospital in Baghdad under a variety of operating circumstances. Even during rapid load changes and door openings, the control system successfully maintained the temperature between 18 and 22 °C and the differential pressure between 3 and 15 Pascals. Four performance scenarios, such as normal (pressure and temperature), high-temperature, high-pressure, and low-pressure cases, were tested. The results showed that the cascade PI control strategy is a reliable solution for critical care settings because it achieves precise environmental control, improves energy efficiency, and ensures compliance with strict healthcare facility standards. Full article

Surgical procedures have significantly contributed to the increased life expectancy of the global population. The surgical procedures are carried out in specialised rooms within a healthcare facility normally designated as operating rooms or operating theatres. These rooms require meticulously designed heating, ventilating, and air conditioning systems to ensure optimal thermal comfort, strict sterility, and effective removal of airborne contaminants and anaesthetic gases. The performance of the system directly affects the risk of surgical site infections and associated post-operative complications. This study presents a computational fluid dynamics analysis of disturbance on airflow and particulate distribution within a representative operating room by the surgical staff and lighting fixtures concerning supply air velocity. The removal of the maximum possible particulate matter, precise control of air temperature and humidity, and unidirectional airflow in the surgical field were incorporated as key design strategies. The species transport model simulations revealed that while laminar airflow offers superior protection in terms of surgical site sterility, its performance is sensitive to disruptions caused by surgical lighting configurations and variations in supply air velocity. The findings highlight the complexities involved in maintaining optimal airflow conditions and underscore the need for integrative air conditioning design approaches that account for optimal design of surgical lighting and operational setups. Full article

The Asian tiger mosquito Aedes albopictus is a highly invasive species capable of transmitting human pathogens. For population management, the sterile insect technique (SIT) is considered an effective and sustainable alternative to conventional methods, such as insecticides and reducing or eliminating breeding sites. The use of symbiotic bacteria to improve the application of SIT or design combined SIT/incompatible insect technique (IIT) approaches is currently considered. In this context, exploring the microbiota of local mosquito populations is crucial for identifying interesting components. This study employed 16S rRNA sequencing and microbiological methods to characterize the diversity of laboratory and wild Ae. albopictus in Greece. Differences were recorded between wild and lab-reared mosquitoes, with laboratory samples exhibiting higher diversity. Laboratory treatment, sex, and developmental stage also resulted in variations between communities. Populations reared in the same facility developed mostly similar bacterial profiles. Two geographically distant wild populations displayed similar bacterial profiles, characterized by seasonal changes in the relative abundance of Pantoea and Zymobacter. Wolbachia was dominant in most groups (63.7% relative abundance), especially in field-caught mosquitoes. It was identified with two strains, wAlbA (21.5%) and wAlbB (42.2%). Other frequent taxa included Elizabethkingia, Asaia, and Serratia. Blood feeding favored an increase in Serratia abundance. Various Enterobacter, Klebsiella, Aeromonas, and Acinetobacter strains were isolated from larval and adult mosquito extracts and could be further characterized as diet supplements. These findings suggest that the microbiota of local populations is highly variable due to multiple factors. However, they retain core elements shared across populations that may exhibit valuable nutritional or functional roles and could be exploited to improve SIT processes. Full article

Medicinal products available on the market should be characterised by therapeutic efficacy, high quality, and safety for patients. They must either be sterile or comply with the appropriate pharmacopoeial microbiological purity requirements. Pharmacopoeial monographs related to microbiological tests of drug quality were also referenced. Despite stringent regulations governing pharmaceutical production, irregularities in the microbiological quality of drugs still occur. These are monitored by relevant agencies, which may order the recall of defective product batches from the market. However, in recent years, numerous cases of microbiological contamination in drugs and drug-related infections have been reported. Both isolated incidents and larger outbreaks or epidemics linked to contaminated medicines have been documented. Various microorganisms, including Gram-negative and Gram-positive bacteria, anaerobes, and yeast-like and mould fungi, have been identified in medicinal products or in patients affected by contaminated drugs. Ensuring the appropriate purity or sterility of pharmaceutical raw materials; maintaining cleanliness in the manufacturing environment, facilities, and equipment; and adhering to hygiene protocols and Good Manufacturing Practice regulations are essential for the production of safe and high-quality medicinal products. The aim of this study is to collect and compile information on the microbiological quality of drugs available on the market, with particular attention to identified irregularities, objectionable microorganisms isolated from medicinal products, and drug-related infections. Full article

Hybrid striped bass (HSB), a cross between white bass (Morone chrysops) and striped bass (Morone saxatilis), has garnered attention in aquaculture due to its adaptability, rapid growth, and high market value. This study investigates the morphometric, nutritional, and blood characteristics of HSB reared in a recirculating aquaculture system (RAS) in Sicily, Italy, over a 22-month grow-out period. The fish were managed under standardized feeding and water quality protocols, with weekly monitoring of the physicochemical parameters. A total of 21 clinically healthy fish, averaging 571.33 ± 129.32 in body weight, were randomly sampled in the spring season from a commercial RAS facility equipped with biological filtration, UV sterilization, and seasonally regulated water parameters. The results revealed strong positive correlations between the morphometric parameters and blood indices, such as red blood cell (RBC) count, hemoglobin (Hb) levels, and hematocrit (Hct), highlighting their importance as health indicators. The proximate composition revealed an average moisture content of 75.55 ± 1.49, crude protein at 20.29 ± 0.26, total lipid at 4.25 ± 0.97, and ash content at 1.69 ± 0.17. Additionally, statistical analyses, including a principal component analysis (PCA), identified relationships between body size, nutritional content, and blood parameters, emphasizing the role of body size in influencing nutritional and health outcomes. The findings of this study are crucial for optimizing farming protocols and improving the health and productivity of HSB in RAS under Mediterranean conditions. Full article

Objective: Current good manufacturing practice (cGMP) guidance for positron emission tomography (PET) drugs has been established in Europe and the United States. In Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) approved the use of radiosynthesizers as medical devices for the in-house manufacturing of PET drugs in hospitals and clinics, regardless of the cGMP environment. Without adequate facilities, equipment, and personnel required by cGMP regulations, the quality assurance (QA) and clinical effectiveness of PET drugs largely depend on the radiosynthesizers themselves. To bridge the gap between radiochemistry standardization and site qualification, the Japanese Society of Nuclear Medicine (JSNM) has issued guidance for the in-house manufacturing of small-scale PET drugs under academic GMP (a-GMP) environments. The goals of cGMP and a-GMP are different: cGMP focuses on process optimization, certification, and commercialization, while a-GMP facilitates the small-scale, in-house production of PET drugs for clinical trials and patient-specific standard of care. Among PET isotopes, N-13 has a short half-life (10 min) and must be synthesized on site. [¹³N]Ammonia ([¹³N]NH₃) is used for myocardial perfusion imaging under the Japan Health Insurance System (JHIS) and was thus selected as a working example for the manufacturing of PET drugs in an a-GMP environment. Methods: A [¹³N]NH₃-radiosynthesizer was installed in a hot cell within an a-GMP-compliant radiopharmacy unit. To comply with a-GMP regulations, the air flow was adjusted through HEPA filters. All cabinets and cells were disinfected to ensure sterility once a month. Standard operating procedures (SOPs) were applied, including analytical methods. Batch records, QA data, and radiation exposure to staff in the synthesis of [¹³N]NH₃ were measured and documented. Results: 2.52 GBq of [¹³N]NH₃ end-of-synthesis (EOS) was obtained in an average of 13.5 min in 15 production runs. The radiochemical purity was more than 99%. Exposure doses were 11 µSv for one production run and 22 µSv for two production runs. The pre-irradiation background dose rate was 0.12 µSv/h. After irradiation, the exposed dosage in the front of the hot cell was 0.15 µSv/h. The leakage dosage measured at the bench was 0.16 µSv/h. The exposure and leakage dosages in the manufacturing of [¹³N]NH₃ were similar to the background level as measured by radiation monitoring systems in an a-GMP environments. All QAs, environmental data, bacteria assays, and particulates met a-GMP compliance standards. Conclusions: In-house a-GMP environments require dedicated radiosynthesizers, documentation for batch records, validation schedules, radiation protection monitoring, air and particulate systems, and accountable personnel. In this study, the in-house manufacturing of [¹³N]NH₃ under a-GMP conditions was successfully demonstrated. These findings support the international harmonization of small-scale PET drug manufacturing in hospitals and clinics for future multi-center clinical trials and the development of a standard of care. Full article

Ethylene oxide (EO) is an industrial chemical and sterilant that is released into ambient air from natural and unregulated anthropogenic sources that contribute to background exogenous exposure and from regulated industrial sources that contribute to additional exogenous exposure for near-facility populations. Metabolic processes contribute to substantial background endogenous exposures to EO, complicating the interpretation of the relation between total background exposure and the health significance of added industrial exogenous exposure. In 2021, Kirman and colleagues characterized the total and endogenous equivalent background concentrations for U.S. populations, which are substantially greater than the USEPA 2016 EO cancer reassessment risk-specific concentrations (0.00011–0.011 ppb), suggesting that the consideration of background exposure could be used as a reality check for the utility of the reassessment in managing EO risk for industrially exposed populations. New exposure biomarker data and background ambient concentration data for EO have become available since the 2021 assessment and are used here to refine the estimates of U.S. population total and endogenous equivalent background EO concentrations. Refined equivalent background concentrations as well as total equivalent exposure estimates for U.S. smokers provide context as to the health significance of near-industry population added exposure and a reality check for the utility of USEPA and TCEQ risk-specific concentrations in managing and communicating EO risk. Full article

Sterilized processed cheese is a dairy product with prolonged shelf life compared to regular processed cheese. The extension of durability is made possible by the thermosterilization of processed cheese, while regular processed cheese is submitted to pasteurization process during manufacturing. Sterilized processed cheese can be classified as long-life foods and their shelf life may reach up to 24 months, if stored at ambient temperature (approx. 25 ± 1 °C). This fact is an advantage over regular processed cheese, which has a shelf life of only around 6 months. Sterilized processed cheese finds application in everyday life when refrigeration facilities are not available; i.e., it is intended for regular retail. However, their most important use is for storage in state material reserves and, moreover, for catering for members of the armed forces and/or members of the integrated rescue system. This review aimed to gather general information on sterilized processed cheeses, their characterization, usage and production. Furthermore, the review discusses the principles of sterilization and factors affecting the course of sterilization focusing on the setting the sterilization limits and sterilization parameters in order to maximize end-product quality. Moreover, last part of the review is devoted to the effect of sterilization and long-term storage on the qualitative parameters of sterilized processed cheese. Full article

As the epidemic affected everyone across the world, the solution to the epidemic was developed globally. Many applications adopt Internet of Things (IoT) technology to detect epidemics, and effective monitoring systems are developed to monitor air pollution, personal transmission, early detection of serious cases, and remote assessment. However, care facilities in an aging society require effective disinfection and sterilization to prevent viral transmission. We integrated the interactive and real-time features of the Internet of Things (IoT) to design and build an intelligent self-propelled sterilization robot for sterilization. Intelligent sterilization and disinfection planning and task allocation mechanisms were designed for sterilization in clinics. For healthcare facilities, the developed robot can reduce the burden on healthcare professionals, help to manage the disinfection and sterilization process, and ensure patient safety. At the same time, robots promote the development of epidemic prevention industries and prepares for future attacks from harmful air pollutants or new infections. Full article

A series of flexible polyacrylonitrile/TiO₂ (PAN/P25) multi-porous nanotubular membranes were successfully constructed by facile electrospinning combined with an ethylene glycol solvothermal induce strategy. The effects of P25 dosage and solvothermal time on the morphology of samples were systematically investigated, which were characterized in terms of surface morphology, microstructure, specific surface area, thermal analysis, wettability, photoelectrochemical and fluorescence spectra. Rhodamine B (RhB) and Escherichia coli (E. coli) were employed as simulated pollutants to evaluate photocatalytic degradation and antibacterial properties of the PAN/P25-3 multi-porous nanotubular membrane. The PAN/P25-3 membrane exhibited the highest photocatalytic degradation efficiency, with 96.1% degradation of RhB within 120 min under a xenon lamp light source and a photocatalytic inactivation rate of 95.8% for E. coli under 365 nm monochromatic light irradiation. The photocatalytic degradation mechanism of the PAN/P25-3 multi-porous nanotubular membrane for RhB was deduced from the results of 3D-EEM fluorescence and scavenger experiments of reactive species. Additionally, the cyclic photodegradation experiments demonstrated that the PAN/P25-3 membrane maintained excellent stability and photocatalytic performance after multiple degradation cycles, confirming its potential for sustainable wastewater treatment applications. Full article

Spore-forming bacterial species pose a serious threat to food plants and healthcare facilities that use high-temperature processing and sterilizing techniques to sanitize medical equipment and food items. These severe processing conditions trigger sporulation, which is the process by which spore-forming bacteria, such as those of the Bacillus and Clostridium species, begin to produce spores, which are extremely resilient entities capable of withstanding adverse environmental circumstances. Additionally, these spores are resistant to a wide range of disinfectants and antibacterial therapies, such as hydrolytic enzymes, radiation, chemicals, and antibiotics. Because of their ability to combat bacteria through several biological pathways, selenium nanoparticles (SeNPs) have emerged as an effective method for either eliminating or preventing the formation of spore-forming bacteria. This review aims to investigate every potential pathway of entry and mechanism by which SeNPs impact bacterial species that produce spores. Additionally, SeNPs’ antibacterial efficacy against several infections is reviewed. To precisely explain the antibacterial mechanism of SeNPs and the various factors that can affect their effectiveness, more research is necessary. Full article

Therapies based on mesenchymal stromal cells (MSCs) have become one of the most significant advancements in veterinary regenerative medicine. The isolation of MSCs is usually performed by enzymatic digestion and requires variable times for cell expansion. In addition, these procedures need to be performed in specialized laboratory facilities. An alternative approach to in vitro-expanded MSC therapy is the use of microfragmented adipose tissue (microfat), which is a rich source of cells and growth factors from the stromal vascular fraction. Recent clinical studies support its safety and efficacy in the treatment of musculoskeletal disorders and wound healing. The aim of the present work was to characterize the microfragmented adipose tissue obtained by a new mechanical device, which provides sterile tissue that is ready for use in the clinic by the veterinarian, avoiding the need for specialized laboratory facilities. Microfat-derived MSCs were compared with enzymatically isolated MSCs in terms of their phenotypic characterization, growth rate and differentiation potential. Conditioned medium derived from microfat culture was evaluated for its ability to promote MSC vitality. No differences were observed between MSCs obtained through mechanical fragmentation and those derived from collagenase digestion of adipose tissue, suggesting that the device could serve as a practical source of microfragmented adipose tissue for use in veterinary clinics. Full article